Synthesis of a theranostic agent: radioiodinated PEGylated PLGA-indocyanine capsules and in vitro determination of their bioaffinity on ovarian, cervical and breast cancer cells

The aim of current study is to synthesize a theranostic (multi-functional) agent, which is targeted on ovary, cervical and breast cancer types with diagnosis and treatment potential and to determine its bioaffinity by using in vitro methods. In conclusion; the designed compound (IPPP), which has flu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of radioanalytical and nuclear chemistry 2016-05, Vol.308 (2), p.659-670
Hauptverfasser: Akman, Levent, Biber Muftuler, Fazilet Zumrut, Bilgi, Ahmet, Yurt Kilcar, Ayfer, Gokulu, Sevki Goksun, Medine, Emin Ilker, Terek, Mustafa Cosan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 670
container_issue 2
container_start_page 659
container_title Journal of radioanalytical and nuclear chemistry
container_volume 308
creator Akman, Levent
Biber Muftuler, Fazilet Zumrut
Bilgi, Ahmet
Yurt Kilcar, Ayfer
Gokulu, Sevki Goksun
Medine, Emin Ilker
Terek, Mustafa Cosan
description The aim of current study is to synthesize a theranostic (multi-functional) agent, which is targeted on ovary, cervical and breast cancer types with diagnosis and treatment potential and to determine its bioaffinity by using in vitro methods. In conclusion; the designed compound (IPPP), which has fluorescence capability (from Indocyanine), encapsulated structure (with PEGylated PLGA), included an anticancer drug (Paclitaxel) for targeting and radionuclidic tracer ( 131 I) content for tracing, has bioaffinity and promise for diagnosis and therapy on ovarian, cervical and breast cancer cell lines.
doi_str_mv 10.1007/s10967-015-4472-z
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808611122</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A448924263</galeid><sourcerecordid>A448924263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-bb4ffe432f83372e1584402431c0b1c83b2b79429568429d6ac38269811d0ec53</originalsourceid><addsrcrecordid>eNp9kc-KFDEQxhtRcFx9AG8BLx7sNf-6O-1tWNbZhQEF9RzS6cpYS08yJpmB3rfyDU3bXgSRQFJUvl9VUV9VvWb0mlHavU-M9m1XU9bUUna8fnxSbVijVM07RZ9WG8pFWzedYM-rFyk9UEp7pcSm-vll9vk7JEwkOGJIiaPxIWW0xBzA5w8kmhEDhhG9yTCSz7e7eVqj_W5box-DnY1HD8SaUzpPkIjxI0FPLphjICNkiMeFxuCXLqUHRjJgMM6hxzyTJX8xEY1_RyzEC1oz_S4yRDApl8K-pMvXNKWX1TNnpgSv_rxX1bePt19v7ur9p939zXZfW6FUrodBOgdScKeE6DiUZUhJuRTM0oFZJQY-dL3kfdOqco-tKRxve8XYSME24qp6u9Y9xfDjDCnrI6ZlAuMhnJNmiqqWMcZ5kb5ZpQczgUbvQo7GLnK9lVL1XPJWFNX1P1TljHBEGzw4LPm_ALYCNoaUIjh9ing0cdaM6sV1vbqui-t6cV0_FoavTCpaf4CoH8I5-rKo_0C_APz8sYc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808611122</pqid></control><display><type>article</type><title>Synthesis of a theranostic agent: radioiodinated PEGylated PLGA-indocyanine capsules and in vitro determination of their bioaffinity on ovarian, cervical and breast cancer cells</title><source>Springer Nature - Complete Springer Journals</source><creator>Akman, Levent ; Biber Muftuler, Fazilet Zumrut ; Bilgi, Ahmet ; Yurt Kilcar, Ayfer ; Gokulu, Sevki Goksun ; Medine, Emin Ilker ; Terek, Mustafa Cosan</creator><creatorcontrib>Akman, Levent ; Biber Muftuler, Fazilet Zumrut ; Bilgi, Ahmet ; Yurt Kilcar, Ayfer ; Gokulu, Sevki Goksun ; Medine, Emin Ilker ; Terek, Mustafa Cosan</creatorcontrib><description>The aim of current study is to synthesize a theranostic (multi-functional) agent, which is targeted on ovary, cervical and breast cancer types with diagnosis and treatment potential and to determine its bioaffinity by using in vitro methods. In conclusion; the designed compound (IPPP), which has fluorescence capability (from Indocyanine), encapsulated structure (with PEGylated PLGA), included an anticancer drug (Paclitaxel) for targeting and radionuclidic tracer ( 131 I) content for tracing, has bioaffinity and promise for diagnosis and therapy on ovarian, cervical and breast cancer cell lines.</description><identifier>ISSN: 0236-5731</identifier><identifier>EISSN: 1588-2780</identifier><identifier>DOI: 10.1007/s10967-015-4472-z</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Breast cancer ; Chemistry ; Chemistry and Materials Science ; Diagnostic Radiology ; Drug delivery systems ; Fluorescence ; Hadrons ; Heavy Ions ; Inorganic Chemistry ; Nuclear Chemistry ; Nuclear Physics ; Ovarian cancer ; Physical Chemistry ; Tracers (Biology)</subject><ispartof>Journal of radioanalytical and nuclear chemistry, 2016-05, Vol.308 (2), p.659-670</ispartof><rights>Akadémiai Kiadó, Budapest, Hungary 2015</rights><rights>COPYRIGHT 2016 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-bb4ffe432f83372e1584402431c0b1c83b2b79429568429d6ac38269811d0ec53</citedby><cites>FETCH-LOGICAL-c388t-bb4ffe432f83372e1584402431c0b1c83b2b79429568429d6ac38269811d0ec53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10967-015-4472-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10967-015-4472-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids></links><search><creatorcontrib>Akman, Levent</creatorcontrib><creatorcontrib>Biber Muftuler, Fazilet Zumrut</creatorcontrib><creatorcontrib>Bilgi, Ahmet</creatorcontrib><creatorcontrib>Yurt Kilcar, Ayfer</creatorcontrib><creatorcontrib>Gokulu, Sevki Goksun</creatorcontrib><creatorcontrib>Medine, Emin Ilker</creatorcontrib><creatorcontrib>Terek, Mustafa Cosan</creatorcontrib><title>Synthesis of a theranostic agent: radioiodinated PEGylated PLGA-indocyanine capsules and in vitro determination of their bioaffinity on ovarian, cervical and breast cancer cells</title><title>Journal of radioanalytical and nuclear chemistry</title><addtitle>J Radioanal Nucl Chem</addtitle><description>The aim of current study is to synthesize a theranostic (multi-functional) agent, which is targeted on ovary, cervical and breast cancer types with diagnosis and treatment potential and to determine its bioaffinity by using in vitro methods. In conclusion; the designed compound (IPPP), which has fluorescence capability (from Indocyanine), encapsulated structure (with PEGylated PLGA), included an anticancer drug (Paclitaxel) for targeting and radionuclidic tracer ( 131 I) content for tracing, has bioaffinity and promise for diagnosis and therapy on ovarian, cervical and breast cancer cell lines.</description><subject>Breast cancer</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Diagnostic Radiology</subject><subject>Drug delivery systems</subject><subject>Fluorescence</subject><subject>Hadrons</subject><subject>Heavy Ions</subject><subject>Inorganic Chemistry</subject><subject>Nuclear Chemistry</subject><subject>Nuclear Physics</subject><subject>Ovarian cancer</subject><subject>Physical Chemistry</subject><subject>Tracers (Biology)</subject><issn>0236-5731</issn><issn>1588-2780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kc-KFDEQxhtRcFx9AG8BLx7sNf-6O-1tWNbZhQEF9RzS6cpYS08yJpmB3rfyDU3bXgSRQFJUvl9VUV9VvWb0mlHavU-M9m1XU9bUUna8fnxSbVijVM07RZ9WG8pFWzedYM-rFyk9UEp7pcSm-vll9vk7JEwkOGJIiaPxIWW0xBzA5w8kmhEDhhG9yTCSz7e7eVqj_W5box-DnY1HD8SaUzpPkIjxI0FPLphjICNkiMeFxuCXLqUHRjJgMM6hxzyTJX8xEY1_RyzEC1oz_S4yRDApl8K-pMvXNKWX1TNnpgSv_rxX1bePt19v7ur9p939zXZfW6FUrodBOgdScKeE6DiUZUhJuRTM0oFZJQY-dL3kfdOqco-tKRxve8XYSME24qp6u9Y9xfDjDCnrI6ZlAuMhnJNmiqqWMcZ5kb5ZpQczgUbvQo7GLnK9lVL1XPJWFNX1P1TljHBEGzw4LPm_ALYCNoaUIjh9ing0cdaM6sV1vbqui-t6cV0_FoavTCpaf4CoH8I5-rKo_0C_APz8sYc</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Akman, Levent</creator><creator>Biber Muftuler, Fazilet Zumrut</creator><creator>Bilgi, Ahmet</creator><creator>Yurt Kilcar, Ayfer</creator><creator>Gokulu, Sevki Goksun</creator><creator>Medine, Emin Ilker</creator><creator>Terek, Mustafa Cosan</creator><general>Springer Netherlands</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7ST</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>SOI</scope></search><sort><creationdate>20160501</creationdate><title>Synthesis of a theranostic agent: radioiodinated PEGylated PLGA-indocyanine capsules and in vitro determination of their bioaffinity on ovarian, cervical and breast cancer cells</title><author>Akman, Levent ; Biber Muftuler, Fazilet Zumrut ; Bilgi, Ahmet ; Yurt Kilcar, Ayfer ; Gokulu, Sevki Goksun ; Medine, Emin Ilker ; Terek, Mustafa Cosan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-bb4ffe432f83372e1584402431c0b1c83b2b79429568429d6ac38269811d0ec53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Breast cancer</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Diagnostic Radiology</topic><topic>Drug delivery systems</topic><topic>Fluorescence</topic><topic>Hadrons</topic><topic>Heavy Ions</topic><topic>Inorganic Chemistry</topic><topic>Nuclear Chemistry</topic><topic>Nuclear Physics</topic><topic>Ovarian cancer</topic><topic>Physical Chemistry</topic><topic>Tracers (Biology)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akman, Levent</creatorcontrib><creatorcontrib>Biber Muftuler, Fazilet Zumrut</creatorcontrib><creatorcontrib>Bilgi, Ahmet</creatorcontrib><creatorcontrib>Yurt Kilcar, Ayfer</creatorcontrib><creatorcontrib>Gokulu, Sevki Goksun</creatorcontrib><creatorcontrib>Medine, Emin Ilker</creatorcontrib><creatorcontrib>Terek, Mustafa Cosan</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Environment Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environment Abstracts</collection><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akman, Levent</au><au>Biber Muftuler, Fazilet Zumrut</au><au>Bilgi, Ahmet</au><au>Yurt Kilcar, Ayfer</au><au>Gokulu, Sevki Goksun</au><au>Medine, Emin Ilker</au><au>Terek, Mustafa Cosan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of a theranostic agent: radioiodinated PEGylated PLGA-indocyanine capsules and in vitro determination of their bioaffinity on ovarian, cervical and breast cancer cells</atitle><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle><stitle>J Radioanal Nucl Chem</stitle><date>2016-05-01</date><risdate>2016</risdate><volume>308</volume><issue>2</issue><spage>659</spage><epage>670</epage><pages>659-670</pages><issn>0236-5731</issn><eissn>1588-2780</eissn><abstract>The aim of current study is to synthesize a theranostic (multi-functional) agent, which is targeted on ovary, cervical and breast cancer types with diagnosis and treatment potential and to determine its bioaffinity by using in vitro methods. In conclusion; the designed compound (IPPP), which has fluorescence capability (from Indocyanine), encapsulated structure (with PEGylated PLGA), included an anticancer drug (Paclitaxel) for targeting and radionuclidic tracer ( 131 I) content for tracing, has bioaffinity and promise for diagnosis and therapy on ovarian, cervical and breast cancer cell lines.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10967-015-4472-z</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0236-5731
ispartof Journal of radioanalytical and nuclear chemistry, 2016-05, Vol.308 (2), p.659-670
issn 0236-5731
1588-2780
language eng
recordid cdi_proquest_miscellaneous_1808611122
source Springer Nature - Complete Springer Journals
subjects Breast cancer
Chemistry
Chemistry and Materials Science
Diagnostic Radiology
Drug delivery systems
Fluorescence
Hadrons
Heavy Ions
Inorganic Chemistry
Nuclear Chemistry
Nuclear Physics
Ovarian cancer
Physical Chemistry
Tracers (Biology)
title Synthesis of a theranostic agent: radioiodinated PEGylated PLGA-indocyanine capsules and in vitro determination of their bioaffinity on ovarian, cervical and breast cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A06%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%20a%20theranostic%20agent:%20radioiodinated%20PEGylated%20PLGA-indocyanine%20capsules%20and%20in%20vitro%20determination%20of%20their%20bioaffinity%20on%20ovarian,%20cervical%20and%20breast%20cancer%20cells&rft.jtitle=Journal%20of%20radioanalytical%20and%20nuclear%20chemistry&rft.au=Akman,%20Levent&rft.date=2016-05-01&rft.volume=308&rft.issue=2&rft.spage=659&rft.epage=670&rft.pages=659-670&rft.issn=0236-5731&rft.eissn=1588-2780&rft_id=info:doi/10.1007/s10967-015-4472-z&rft_dat=%3Cgale_proqu%3EA448924263%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1808611122&rft_id=info:pmid/&rft_galeid=A448924263&rfr_iscdi=true